Face and Neck Atopic Dermatitis research hub

A Phase 3b, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lebrikizumab in Adult and Adolescent Participants with Moderate-to-Severe Face and Neck Atopic Dermatitis

This clinical trial is testing a new injection called lebrikizumab for people with moderate-to-severe eczema on their face and neck. Researchers want to see if the medicine can clear skin, soothe itching, and improve daily life over 16 weeks compared to a dummy injection (placebo).